RELMADA THERAPEUTICS, INC. (RLMD)

4.33 -4.20% (-0.19)

Over 1M: -18.5%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

4.5 5 5.5
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q1 '22 — Operating Cash Flow: -20.9M Q1 '22 — Net Income: -42.6M Q2 '22 — Operating Cash Flow: -37.7M Q2 '22 — Net Income: -34.4M Q3 '22 — Operating Cash Flow: -19.4M Q3 '22 — Net Income: -39.7M Q4 '22 — Operating Cash Flow: -21.6M Q4 '22 — Net Income: -39.9M Q1 '23 — Operating Cash Flow: -26.9M Q1 '23 — Net Income: -39.4M Q2 '23 — Operating Cash Flow: -35.9M Q2 '23 — Net Income: -37.9M Q3 '23 — Operating Cash Flow: -16.5M Q3 '23 — Net Income: -26.3M Q4 '23 — Operating Cash Flow: -13.3M Q4 '23 — Net Income: -25.3M Q1 '24 — Operating Cash Flow: -11.6M Q1 '24 — Net Income: -22M Q2 '24 — Operating Cash Flow: -10.2M Q2 '24 — Net Income: -25.2M Q3 '24 — Operating Cash Flow: -13M Q3 '24 — Net Income: -21.8M Q4 '24 — Operating Cash Flow: -13.3M Q4 '24 — Net Income: -17.8M Q1 '25 — Operating Cash Flow: -16.7M Q1 '25 — Net Income: -21.7M Q2 '25 — Operating Cash Flow: -8.8M Q2 '25 — Net Income: -18.7M Q3 '25 — Operating Cash Flow: -18.1M Q3 '25 — Net Income: -17.6M Q4 '25 — Operating Cash Flow: -6.4M Q4 '25 — Net Income: -9.9M Q1 '26 — Operating Cash Flow: -6.7M Q1 '26 — Net Income: -10.1M Q2 '26 — Operating Cash Flow: -14.6M Q2 '26 — Net Income: -19.9M Q3 '26 — Operating Cash Flow: -15.1M Q3 '26 — Net Income: -19.1M Q4 '26 — Operating Cash Flow: -9.6M Q4 '26 — Net Income: -12.9M -36M -27M -18M -9M 0
Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2014-02-28, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

10.0
Asset turnover 1.4e-05×
Gross margin 14.9%
Accruals —
Capex / sales —
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROA —
ROCE —
ROE —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.5
Current ratio 29.5×
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 29.5×
Cash / Debt —
Cash runway —
F-score —
Interest cover —
Payout —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -50.6%
Sales Q/Q -70.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Shares change —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.